CONGESTIVE HEART FAILURE GUIDELINES FROM METRICOR FOR COMMUNITY HOSPITAL CUT TREATMENT COSTS BY 25%: DRUG THERAPY INCREASES AS PERCENTAGE OF COST
Congestive heart failure treatment guidelines developed for a community hospital in consultation with Metricor indicate that careful formulary selection can contribute to a 25% reduction in overall treatment costs per in-patient, according to a recent report by The Wilkerson Group. Metricor is a clinical practice guidelines development firm, created by a spin-off of three service firms from Louisville, Ky.-based Humana in 1992.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth